University of Cincinnati
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of Cincinnati sits in the top decile of US sponsors by registered trial count (#133 of 15,742 sponsors by registered trial count).
University of Cincinnati: 245 sponsored US clinical trials, 34 recruiting.
University of Cincinnati sponsors 245 registered US clinical trials on ClinicalTrials.gov, 34 of them currently recruiting, and 172 completed. 65 of these trials are in Phase 3-4 (later-stage) and 56 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 9 trials.
Top-decile sponsor footprint
University of Cincinnati ranks in the top decile of sponsors by registered trial count (#133 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
172 of 189 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
245 total, page 4 of 5
Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Response in Multisystem Trauma Patients
NCT01477697
Ability of Caregivers to Provide Ventilation With the SAVe Resuscitator in a Model
NCT01477710
Letrozole for Lymphangioleiomyomatosis
NCT01353209
The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
NCT01335230
Clinician Ability to Predict the Presence of Nosocomial Pneumonia Based on Bronchoscopic Findings
NCT01904305
The Spot Sign for Predicting and Treating ICH Growth Study
NCT00810888
Peroxisomal Defects and Familial Risk for Bipolar Disorder
NCT01237379
Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients
NCT01336296
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
NCT01202864
Monitoring of Delayed Ischemia After Subarachnoid Hemorrhage
NCT01406457
Radiation Planning Study for High Grade Brain Tumors
NCT01191346
Hypertonic Saline vs. Mannitol for Elevated Intercranial Pressure
NCT01111682
Effects of Transport on Patients With Traumatic Brain Injury
NCT01077089
Challenging the Gold Standard: Pilot Study Comparing Continuous Glucose Monitoring System (CGMS), Capillary Glucose Monitors and 3 Hour Glucose Tolerance Test (GTT) to Diagnose Gestational Diabetes Mellitus (GDM)
NCT01074489
Smoking-Cessation and Stimulant Treatment (S-CAST)
NCT01077024
Pre-hospital Hypoxemia in Trauma Patients
NCT01074983
Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline
NCT01746303
Measurements to Assess Severity of Epicardial Stenoses
NCT00760630
Positron Emission Mammography (PEM) Biopsy Accessory for the Diagnosis of Breast Cancer
NCT00981812
Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke
NCT00894803
Rituximab for Pulmonary Sarcoidosis
NCT00855205
Study to Measure the Prevalence of Asynchrony In Mechanically Ventilated Patients
NCT01049958
Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania
NCT00917501
Desensitization in Kidney Transplantation
NCT00908583
Multimodal Neuroimaging of Treatment Effects in Adolescent Mania
NCT00893581
Observational Study of Cortical Spreading Depression in Human Brain Trauma
NCT00803036
Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study
NCT00885495
Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
NCT00845507
The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis
NCT00794274
Energy Metabolism and Cognitive Aging
NCT00777010
Quetiapine in Melancholic Depression
NCT01200901
Randomized Trial for Mixed Acute Rejection
NCT00771875
Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients
NCT00782821
Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients
NCT00771745
Standardized Criteria to Judge Diagnostic Urethrocystoscopy Skills
NCT00631761
Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension
NCT00581607
Efficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young Adults
NCT00550394
Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation Analysis
NCT00875940
An Eval of Neurocognitive Function, Oxidative Damage, and Their Association With Outcomes in METH and Cocaine Abusers.
NCT00628927
Modifying Dietary Behavior in Adolescents With Elevated Blood Pressure
NCT00585832
Functional and Neurochemical Brain Changes Bipolar Depression
NCT00608296
Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)
NCT00603434
Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia
NCT00585390
Functional and Neurochemical Brain Changes in First-episode Bipolar Mania
NCT00609193
Methylphenidate for the Treatment of Gait Impairment in Parkinson's Disease
NCT00526630
Use of Armodafinil for Fatigue in Sarcoidosis
NCT00555347
Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention
NCT00618436
Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder
NCT00511810
Pilot Study of Betahistine Dihydrochloride in the Treatment of Major Depression With Atypical Features
NCT00585585
Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease
NCT00477802
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 23 |
| Phase 2 | 33 |
| Phase 3 | 19 |
| Phase 4 | 46 |
Therapeutic Areas
What is open in the University of Cincinnati pipeline
34 recruiting of 245 indexed (14% open); 172 completed (70%).
Phase mix: 65 late (III/IV) vs 56 early (I/II) (balanced across stages).
Top condition: Stroke (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Cincinnati: open-pipeline peers nationwide
Peers matched on 245 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
University of Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 245 trials (± recruiting share)
- Shire · 245 trials · 0% recruiting
- State University of New York at Buffalo · 243 trials · 21% recruiting
- Masonic Cancer Center, University of Minnesota · 249 trials · 14% recruiting
- University of Massachusetts, Worcester · 240 trials · 13% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Milton S. Hershey Medical Center · 14% recruiting · 396 trials
- Johns Hopkins Bloomberg School of Public Health · 14% recruiting · 187 trials
- BeiGene · 14% recruiting · 65 trials
- Seattle Institute for Biomedical and Clinical Research · 14% recruiting · 43 trials
Related
What to do with this University of Cincinnati page
245 registered trials is a research-attention snapshot, not an endorsement of University of Cincinnati or any single study.
- 34 of University of Cincinnati's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition University of Cincinnati studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Cincinnati pipeline card: 245 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.